Environmental risk assessment of medicinal products for human use

Current effective version

Adopted guideline

Currently under revision - see below

Reference numberCPMP/SWP/4447/00
Effective from01/12/2006
KeywordsEnvironmental risk assessment (ERA), persistence, bioaccumulation, toxicity, PBT, predicted environmental concentration (PEC), Phase I, Phase II
DescriptionThis document describes the assessment of potential environmental risks of human medicinal products. Read together with questions and answers.

Document history

Revision 1

In progress

PDF iconConcept paper

Published: 04/05/2014

Deadline for comments: 31/10/2016

First version

Current version

Adopted guideline

In operation: 01/12/2006–present

Related content

How useful was this page?

Add your rating